Notably, several recent findings highlight the roles of BMAL1 and REV-ERBα as regulators of disease severity in patients diagnosed with acute respiratory syndrome-Coronavirus-2 (SARS-CoV-2) infection [22]. Here, BMAL1 is linked to COVID-19.